XML 44 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Basis of Presentation (Tables)
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Components of Marketable Securities
As of September 30, 2023 and December 31, 2022, marketable securities consisted of the following ($ in thousands):
 September 30, 2023
 CostGross
Unrealized (Loss) Gain 		Carrying Value
Equity securities:
Investment funds - debt securities$38,886 $(6,814)$32,072 
Common stock, preferred stock, and stock funds51,026 7,088 58,114 
Total - Marketable securities $89,912 $274 $90,186 

 December 31, 2022
 CostGross
Unrealized Loss		Carrying Value
Equity securities:
Investment funds - debt securities$43,155 $(6,771)$36,384 
Common stock, preferred stock, and stock funds78,481 (2,122)76,359 
Total - Marketable securities $121,636 $(8,893)$112,743 
Schedule of Changes in Accumulated Other Comprehensive Income, Net by Component
Changes in Accumulated Other Comprehensive Income, Net by Component

Essex Property Trust, Inc.
($ in thousands):
 Change in fair
value and amortization
of swap settlements
Balance at December 31, 2022$46,466 
Other comprehensive income before reclassification8,877 
Amounts reclassified from accumulated other comprehensive income 15 
Other comprehensive income8,892 
Balance at September 30, 2023$55,358 


Essex Portfolio, L.P.
($ in thousands):
 Change in fair
value and amortization
of swap settlements
Balance at December 31, 2022$52,010 
Other comprehensive income before reclassification9,190 
Amounts reclassified from accumulated other comprehensive income15 
Other comprehensive income9,205 
Balance at September 30, 2023$61,215 
Schedule of Changes to the Redemption Value of Noncontrolling Interests
The changes in the redemption value of redeemable noncontrolling interests for the nine months ended September 30, 2023 is as follows ($ in thousands):
Balance at December 31, 2022$27,150 
Reclassification due to change in redemption value and other2,810 
Balance at September 30, 2023$29,960 
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 September 30, 2023December 31, 2022September 30, 2022December 31, 2021
Cash and cash equivalents - unrestricted$391,994 $33,295 $42,711 $48,420 
Cash and cash equivalents - restricted8,503 9,386 10,858 10,218 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statement of cash flows$400,497 $42,681 $53,569 $58,638 
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 September 30, 2023December 31, 2022September 30, 2022December 31, 2021
Cash and cash equivalents - unrestricted$391,994 $33,295 $42,711 $48,420 
Cash and cash equivalents - restricted8,503 9,386 10,858 10,218 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statement of cash flows$400,497 $42,681 $53,569 $58,638